This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec 1;26(12):1198.

doi: 10.5588/ijtld.22.0522.

Tailored TB preventive treatment for drug-resistant TB - failing the test for appropriateness?

J Noeske¹, C Kuaban²

Affiliations

PMID: 36447329
DOI: 10.5588/ijtld.22.0522

Comment

Tailored TB preventive treatment for drug-resistant TB - failing the test for appropriateness?

J Noeske et al. Int J Tuberc Lung Dis. 2022.

. 2022 Dec 1;26(12):1198.

doi: 10.5588/ijtld.22.0522.

Authors

J Noeske¹, C Kuaban²

Affiliations

¹ Independent Consultant, Emana, Yaounde, Cameroon.
² University of Yaounde 1, Yaounde, Cameroon.

PMID: 36447329
DOI: 10.5588/ijtld.22.0522

No abstract available

PubMed Disclaimer

Comment in

Tailored TPT for drug-resistant TB - promoting equity and access to optimal care.
Khan U, Guglielmetti L. Khan U, et al. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):89b-90. doi: 10.5588/ijtld.22.0538. Int J Tuberc Lung Dis. 2023. PMID: 36853142 No abstract available.

Comment on

Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB.
Khan U, Guglielmetti L. Khan U, et al. Int J Tuberc Lung Dis. 2022 Sep 1;26(9):900-901. doi: 10.5588/ijtld.22.0328. Int J Tuberc Lung Dis. 2022. PMID: 35996292 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc